As of 2024-12-11, the Relative Valuation of Pharmala Biotech Holdings Inc (MDMA.CN) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.32 CAD, the upside of Pharmala Biotech Holdings Inc based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2024-11-15 | -45.18 |
| 2024-11-14 | -42.36 |
| 2024-11-13 | -41.65 |
| 2024-11-12 | -36.71 |
| 2024-11-11 | -40.94 |
| 2024-11-08 | -32.47 |
| 2024-11-07 | -31.06 |
| 2024-11-06 | -26.12 |
| 2024-11-05 | -24.71 |
| 2024-11-04 | -22.59 |
| 2024-11-01 | -25.41 |
| 2024-10-31 | -24.00 |
| 2024-10-30 | -24.71 |
| 2024-10-29 | -26.83 |
| 2024-10-28 | -25.41 |
| 2024-10-25 | -24.71 |
| 2024-10-24 | -25.41 |
| 2024-10-23 | -25.41 |
| 2024-10-22 | -24.00 |
| 2024-10-21 | -25.41 |
| 2024-10-18 | -20.47 |
| 2024-10-17 | -19.77 |
| 2024-10-16 | -21.88 |
| 2024-10-15 | -18.35 |
| 2024-10-11 | -14.82 |
| 2024-10-10 | -14.12 |
| 2024-10-09 | -14.12 |
| 2024-10-08 | -14.12 |
| 2024-10-07 | -12.00 |
| 2024-10-04 | -12.00 |
| 2024-10-03 | -12.00 |
| 2024-10-02 | -12.71 |
| 2024-10-01 | -10.59 |
| 2024-09-30 | -10.59 |
| 2024-09-27 | -10.59 |
| 2024-09-26 | -11.29 |
| 2024-09-25 | -12.00 |
| 2024-09-24 | -12.00 |
| 2024-09-23 | -12.00 |
| 2024-09-20 | -12.00 |
| 2024-09-19 | -12.71 |
| 2024-09-18 | -12.00 |
| 2024-09-17 | -12.00 |
| 2024-09-16 | -12.71 |
| 2024-09-13 | -12.71 |
| 2024-09-12 | -13.41 |
| 2024-09-11 | -13.41 |
| 2024-09-10 | -12.00 |
| 2024-09-09 | -11.29 |
| 2024-09-06 | -10.59 |